|
US4217344A
(en)
|
1976-06-23 |
1980-08-12 |
L'oreal |
Compositions containing aqueous dispersions of lipid spheres
|
|
US4900747A
(en)
|
1984-03-19 |
1990-02-13 |
The Rockefeller University |
Method and agents for removing advanced glycosylation endproducts
|
|
US5811075A
(en)
|
1984-03-19 |
1998-09-22 |
The Rockefeller University |
Method and agents for removing advanced glycosylation endproducts
|
|
AU600306B2
(en)
|
1986-09-12 |
1990-08-09 |
Rockefeller University, The |
Methods and agents for removing advanced glycosylation endproducts
|
|
US4917951A
(en)
|
1987-07-28 |
1990-04-17 |
Micro-Pak, Inc. |
Lipid vesicles formed of surfactants and steroids
|
|
US4911928A
(en)
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US4965288A
(en)
|
1988-02-25 |
1990-10-23 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IN172208B
(enExample)
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US20080063603A1
(en)
|
1990-04-02 |
2008-03-13 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US20040208826A1
(en)
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6372249B1
(en)
|
1991-12-16 |
2002-04-16 |
Baylor College Of Medicine |
Senscent cell-derived inhibitors of DNA synthesis
|
|
EP0617599B1
(fr)
|
1991-12-20 |
1996-10-16 |
Technomed Medical Systems |
Appareil de therapie par ultrasons emettant des ondes ultrasoniques produisant des effets thermiques et des effets de cavitation
|
|
US5624804A
(en)
*
|
1991-12-20 |
1997-04-29 |
The Rockefeller University |
Immunochemical detection of In vivo advanced glycosylation end products
|
|
WO1994000592A1
(en)
|
1992-06-26 |
1994-01-06 |
Exocell, Inc. |
Monoclonal antibodies against glycated low density lipoprotein
|
|
US5620479A
(en)
|
1992-11-13 |
1997-04-15 |
The Regents Of The University Of California |
Method and apparatus for thermal therapy of tumors
|
|
US5518720A
(en)
|
1992-12-30 |
1996-05-21 |
Exocell, Inc. |
Treatment of complications of diabetes with substances reactive with the fructosyl-lysine structure in glycated albumin
|
|
US6387373B1
(en)
|
1993-01-15 |
2002-05-14 |
Novavax, Inc. |
Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
|
|
US5744300A
(en)
|
1993-03-24 |
1998-04-28 |
Geron Corporation |
Methods and reagents for the identification and regulation of senescence-related genes
|
|
WO1994025616A1
(en)
|
1993-04-28 |
1994-11-10 |
Worcester Foundation For Experimental Biology |
Cell-targeted lytic pore-forming agents
|
|
EP0802797A1
(en)
|
1994-02-03 |
1997-10-29 |
The Picower Institute For Medical Research |
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
|
|
US6410598B1
(en)
|
1994-02-03 |
2002-06-25 |
Michael P. Vitek |
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
|
|
CA2208411A1
(en)
|
1994-12-30 |
1996-07-11 |
Alteon, Inc. |
Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
|
|
US5744318A
(en)
|
1994-12-30 |
1998-04-28 |
Alteon Inc. |
Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples
|
|
US6176842B1
(en)
|
1995-03-08 |
2001-01-23 |
Ekos Corporation |
Ultrasound assembly for use with light activated drugs
|
|
AU6907496A
(en)
|
1995-08-25 |
1997-03-19 |
Case Western Reserve University |
Process for detecting pentosidine and for assessing the biological age of a biological sample
|
|
US5620409A
(en)
|
1995-09-15 |
1997-04-15 |
The Research Foundation Of State University Of New York |
Method for inhibiting clot formation
|
|
JP3579549B2
(ja)
|
1995-10-24 |
2004-10-20 |
株式会社トクヤマ |
糖尿病または糖尿病合併症用マーカーとしての使用
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US5664570A
(en)
|
1996-02-20 |
1997-09-09 |
Svc |
Apparatus for applying high-intensity ultrasonic waves to a target volume within a human or animal body
|
|
US5908925A
(en)
|
1996-06-27 |
1999-06-01 |
Exocell, Inc. |
Genetically engineered immunoglobulins with specificity for glycated albumin
|
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
|
US7258857B2
(en)
|
1996-11-22 |
2007-08-21 |
The Trustees Of Columbia University In The City Of New York |
Rage-related methods for treating inflammation
|
|
WO2000020621A1
(en)
|
1998-10-06 |
2000-04-13 |
The Trustees Of Columbia University In The City Of New York |
Extracellular novel rage binding protein (en-rage) and uses thereof
|
|
US6245318B1
(en)
|
1997-05-27 |
2001-06-12 |
Mallinckrodt Inc. |
Selectively binding ultrasound contrast agents
|
|
US7101838B2
(en)
|
1997-08-05 |
2006-09-05 |
The Trustees Of Columbia University In The City Of New York |
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
|
|
CA2296598A1
(en)
|
1997-08-08 |
1999-02-18 |
University Of Washington |
Isolation of a novel senescence-factor gene, p23
|
|
US6380165B1
(en)
|
1997-09-19 |
2002-04-30 |
The Picower Institute For Medical Research |
Immunological advanced glycation endproduct crosslink
|
|
US6896659B2
(en)
|
1998-02-06 |
2005-05-24 |
Point Biomedical Corporation |
Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
|
|
JP4016304B2
(ja)
|
1998-02-26 |
2007-12-05 |
日本油脂株式会社 |
モノクローナル抗体、ハイブリッド細胞、およびモノクローナル抗体の製造方法
|
|
JP2002517224A
(ja)
|
1998-06-09 |
2002-06-18 |
アルテオン インコーポレーテッド |
生体サンプル内におけるグアニジノ基由来進行グリコシル化最終生成物に特異的なモノクローナル抗体
|
|
US6753150B2
(en)
*
|
1998-10-05 |
2004-06-22 |
The Trustees Of Columbia University In The City Of New York |
Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
|
|
US6309355B1
(en)
|
1998-12-22 |
2001-10-30 |
The Regents Of The University Of Michigan |
Method and assembly for performing ultrasound surgery using cavitation
|
|
JP2002538170A
(ja)
|
1999-03-02 |
2002-11-12 |
セントコール， インコーポレイテッド |
喘息の治療における抗−ＴＮＦα抗体
|
|
US6067859A
(en)
|
1999-03-04 |
2000-05-30 |
The Board Of Regents, The University Of Texas System |
Optical stretcher
|
|
GEP20104998B
(en)
|
1999-06-25 |
2010-06-10 |
Genentech Inc |
Humanized antibody which binds erbb2 and blocks activation by ligand receptor of erbb2 (variants) and use of the composition comprising these antibodies methods for treating cancer
|
|
CA2382095A1
(en)
|
1999-08-13 |
2001-02-22 |
The Trustees Of Columbia University In The City Of New York |
Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof
|
|
WO2001018060A1
(fr)
|
1999-09-08 |
2001-03-15 |
Toray Industries, Inc. |
Materiaux de circulation extracorporelle, adsorbants de facteurs de complication diabetique, reservoirs servant a eliminer des facteurs de complication diabetique et procede d'elimination de facteurs de complication diabetique
|
|
US6853864B2
(en)
|
2000-02-02 |
2005-02-08 |
Catholic University Of America, The |
Use of electromagnetic fields in cancer and other therapies
|
|
DK1272647T3
(en)
|
2000-04-11 |
2014-12-15 |
Genentech Inc |
Multivalent antibodies and uses thereof
|
|
WO2001089584A2
(en)
|
2000-05-23 |
2001-11-29 |
Amersham Health As |
Contrast agents
|
|
NO312338B1
(no)
|
2000-08-25 |
2002-04-29 |
Gunnar Myhr |
Anordning for selektiv celle- eller virusödeleggelse hos en levende organisme
|
|
US6946292B2
(en)
*
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
CN2445326Y
(zh)
|
2000-10-09 |
2001-08-29 |
刘永详 |
测定被糖化蛋白的免疫分析装置
|
|
US6676963B1
(en)
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
|
US6821274B2
(en)
|
2001-03-07 |
2004-11-23 |
Gendel Ltd. |
Ultrasound therapy for selective cell ablation
|
|
US7481781B2
(en)
|
2000-11-17 |
2009-01-27 |
Gendel Limited |
Ultrasound therapy
|
|
US20040106867A1
(en)
|
2001-01-03 |
2004-06-03 |
Yoram Eshel |
Non-invasive ultrasonic body contouring
|
|
US7347855B2
(en)
|
2001-10-29 |
2008-03-25 |
Ultrashape Ltd. |
Non-invasive ultrasonic body contouring
|
|
DE60202008T2
(de)
|
2001-03-22 |
2005-12-01 |
Roche Diagnostics Gmbh |
Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten
|
|
WO2003008446A1
(en)
*
|
2001-07-19 |
2003-01-30 |
Mitsubishi Pharma Corporation |
Polypeptides relating to signal transfer of advanced glycation end product receptor
|
|
JP4012722B2
(ja)
|
2001-11-22 |
2007-11-21 |
株式会社トランスジェニック |
カルボキシメチル化ペプチドに対する抗体
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7541150B2
(en)
|
2002-04-08 |
2009-06-02 |
University Of Louisville Research Foundation, Inc |
Method for the diagnosis and prognosis of malignant diseases
|
|
JP4468810B2
(ja)
|
2002-07-24 |
2010-05-26 |
キューエルティー インコーポレーティッド |
ピラゾリルベンゾチアゾール誘導体および治療薬としてのそれらの使用法
|
|
CN1774445A
(zh)
|
2002-08-16 |
2006-05-17 |
惠氏公司 |
用于治疗rage相关病症的组合物和方法
|
|
US20070128117A1
(en)
|
2003-02-04 |
2007-06-07 |
Bracco International B.V. |
Ultrasound contrast agents and process for the preparation thereof
|
|
AU2004215125B2
(en)
|
2003-02-26 |
2011-01-06 |
Institute For Research In Biomedicine |
Monoclonal antibody production by EBV transformation of B cells
|
|
EP1601969A2
(en)
|
2003-03-08 |
2005-12-07 |
Auvation Ltd |
Markers for colorectal cancer
|
|
EP1648314A2
(de)
|
2003-07-31 |
2006-04-26 |
Woodwelding AG |
Verfahren und vorrichtung zur förderung der geweberegeneration an wundflächen
|
|
US7358226B2
(en)
|
2003-08-27 |
2008-04-15 |
The Regents Of The University Of California |
Ultrasonic concentration of drug delivery capsules
|
|
WO2005070472A2
(en)
|
2004-01-20 |
2005-08-04 |
Sunnybrook And Women's College Health Sciences Centre, |
High frequency ultrasound imaging using contrast agents
|
|
JP2007523908A
(ja)
|
2004-02-17 |
2007-08-23 |
ダイナミス セラピューティクス インコーポレイテッド |
フルクトサミン３キナーゼ並びにコラーゲン及びエラスチンの形成
|
|
US7470521B2
(en)
*
|
2004-07-20 |
2008-12-30 |
Critical Therapeutics, Inc. |
RAGE protein derivatives
|
|
MX2007001559A
(es)
|
2004-08-03 |
2007-04-10 |
Transtech Pharma Inc |
Proteinas de fusion de receptor para productos finales glicados avanzados y metodos de uso.
|
|
GB0422525D0
(en)
|
2004-10-11 |
2004-11-10 |
Luebcke Peter |
Dermatological compositions and methods
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
US7846100B2
(en)
|
2005-03-03 |
2010-12-07 |
Bracco International Bv |
Medical imaging system based on a targeted contrast agent
|
|
JP2006249015A
(ja)
|
2005-03-11 |
2006-09-21 |
Mochida Pharmaceut Co Ltd |
細胞老化抑制剤
|
|
CN101120019A
(zh)
|
2005-04-05 |
2008-02-06 |
株式会社Jms |
对3,4-DGE来源的AGEs特异性反应的抗体
|
|
JP2006288864A
(ja)
|
2005-04-13 |
2006-10-26 |
Padoru:Kk |
外科手術用の骨固定具
|
|
US20070225242A1
(en)
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20070059247A1
(en)
|
2005-08-30 |
2007-03-15 |
Lindner Jonathan R |
Deposit contrast agents and related methods thereof
|
|
US20070065415A1
(en)
|
2005-09-16 |
2007-03-22 |
Kleinsek Donald A |
Compositions and methods for the augmentation and repair of defects in tissue
|
|
US20070083120A1
(en)
|
2005-09-22 |
2007-04-12 |
Cain Charles A |
Pulsed cavitational ultrasound therapy
|
|
US20070078290A1
(en)
|
2005-09-30 |
2007-04-05 |
Esenaliev Rinat O |
Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues
|
|
US7766833B2
(en)
|
2005-11-23 |
2010-08-03 |
General Electric Company |
Ablation array having independently activated ablation elements
|
|
JP4779115B2
(ja)
*
|
2005-12-16 |
2011-09-28 |
国立大学法人東北大学 |
早期肺癌の術後予後検査方法
|
|
EP1988918A4
(en)
|
2006-02-22 |
2010-04-28 |
Novavax Inc |
ADJUVANZ AND VACCINE COMPOSITIONS
|
|
WO2007100770A2
(en)
|
2006-02-28 |
2007-09-07 |
Elan Pharmaceuticals, Inc. |
Methods of treating inflammatory and autoimmune diseases with natalizumab
|
|
TW201531484A
(zh)
|
2007-05-21 |
2015-08-16 |
Alder Biopharmaceuticals Inc |
抗ＴＮＦ-α之抗體及其用途
|
|
US20100249038A1
(en)
*
|
2007-06-12 |
2010-09-30 |
Board Of Regents, University Of Texas System |
Antagonists of the receptor for advanced glycation end-products (rage)
|
|
ES2564634T3
(es)
|
2007-06-14 |
2016-03-28 |
Galactica Pharmaceuticals, Inc. |
Proteínas de fusión de RAGE
|
|
JP2007277263A
(ja)
|
2007-07-13 |
2007-10-25 |
Transgenic Inc |
カルボキシメチル化タンパク質に対する抗体
|
|
US20120156134A1
(en)
|
2007-12-20 |
2012-06-21 |
Shayne Squires |
Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
|
|
US7751057B2
(en)
|
2008-01-18 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Magnetomotive optical coherence tomography
|
|
DE102008009461A1
(de)
|
2008-02-15 |
2009-08-20 |
Beiersdorf Ag |
Verfahren zur Reduzierung der Zeichen der Hautalterung
|
|
KR101603917B1
(ko)
*
|
2008-05-09 |
2016-03-17 |
애브비 인코포레이티드 |
최종 당화 산물의 수용체(ｒａｇｅ)에 대한 항체 및 이의 용도
|
|
ES2616728T3
(es)
|
2008-05-23 |
2017-06-14 |
Siwa Corporation |
Procedimientos y composiciones para facilitar la regeneración
|
|
JP5229473B2
(ja)
|
2008-06-04 |
2013-07-03 |
財団法人ヒューマンサイエンス振興財団 |
超音波医療装置
|
|
US20110319499A1
(en)
|
2008-06-30 |
2011-12-29 |
The Johns Hopkins University |
Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
|
|
WO2010095461A1
(ja)
|
2009-02-20 |
2010-08-26 |
国立大学法人東京大学 |
新規モノクローナル抗体、並びにその使用
|
|
US8883721B2
(en)
|
2009-05-12 |
2014-11-11 |
Mcgill University |
Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
|
|
WO2011035104A1
(en)
|
2009-09-17 |
2011-03-24 |
Sanuwave, Inc. |
Methods and devices for cleaning and sterilization with shock waves
|
|
US20110070227A1
(en)
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
|
US20130058921A1
(en)
|
2009-10-30 |
2013-03-07 |
Frits VAN RHEE |
Use of autologous effector cells and antibodies for treatment of multiple myeloma
|
|
WO2011101039A1
(en)
|
2010-02-22 |
2011-08-25 |
Universite Pierre Et Marie Curie (Paris 6) |
Apparatus for the treatment of brain affections and method implementing thereof
|
|
KR101351181B1
(ko)
|
2010-05-11 |
2014-01-14 |
가천대학교 산학협력단 |
단핵식세포계 세포 내에서 ａｇｅ-알부민의 합성 저해 또는 분비 저해에 의한 세포사 유도 저해 방법
|
|
WO2012047629A2
(en)
|
2010-09-27 |
2012-04-12 |
Siwa Corporation |
Selective removal of age-modified cells for treatment of ather0sclerosis
|
|
US8721571B2
(en)
|
2010-11-22 |
2014-05-13 |
Siwa Corporation |
Selective removal of cells having accumulated agents
|
|
WO2012135616A1
(en)
|
2011-03-31 |
2012-10-04 |
Siwa Corporation |
Vaccination against advanced glycation end-products
|
|
UA112434C2
(uk)
|
2011-05-27 |
2016-09-12 |
Ґлаксо Ґруп Лімітед |
Антигензв'язувальний білок, який специфічно зв'язується з всма
|
|
KR102068728B1
(ko)
|
2011-07-10 |
2020-01-21 |
가이디드 테라피 시스템스, 엘.엘.씨. |
초음파 치료를 위한 방법 및 시스템
|
|
US8954155B2
(en)
|
2011-09-19 |
2015-02-10 |
Biotalk Technologies Inc |
Apparatus and method for rejuvenating skin
|
|
WO2013041707A1
(en)
|
2011-09-23 |
2013-03-28 |
Julius-Maximilians-Universität Würzburg |
Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site
|
|
US20140322216A1
(en)
|
2011-11-08 |
2014-10-30 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
KR101939401B1
(ko)
|
2011-11-10 |
2019-01-16 |
가천대학교 산학협력단 |
단핵식세포계 세포의 ａｇｅ-알부민 합성 또는 분비 저해제를 유효성분으로 포함하는 허혈성 심장질환 예방 또는 치료용 조성물
|
|
BR112014014529A2
(pt)
|
2011-12-13 |
2019-09-24 |
Buck Inst For Res On Aging |
métodos para melhorar terapias médicas
|
|
KR102084806B1
(ko)
|
2012-02-17 |
2020-03-04 |
시애틀 지네틱스, 인크. |
인테그린 αvβ6에 대한 항체 및 암을 치료하기 위한 그의 용도
|
|
TWI557112B
(zh)
|
2012-03-05 |
2016-11-11 |
百靈佳殷格翰國際股份有限公司 |
β－分泌酶抑制劑
|
|
US20130288980A1
(en)
|
2012-04-02 |
2013-10-31 |
Buck Institute For Research On Aging |
Targeting senescent and cancer cells for selective killing by interference with foxo4
|
|
US10379026B2
(en)
|
2012-08-29 |
2019-08-13 |
Inguran, Llc |
Cell processing using magnetic particles
|
|
KR101520336B1
(ko)
|
2012-11-30 |
2015-05-14 |
전남대학교산학협력단 |
패혈증 비브리오균의 편모 구성성분인 플라젤린과 병원체의 항원 단백을 융합시킨 재조합 단백을 포함하는 노화 예방, 개선 또는 치료용 조성물
|
|
US10279018B2
(en)
|
2012-12-03 |
2019-05-07 |
Unity Biotechnology, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
EP2742935A1
(en)
|
2012-12-14 |
2014-06-18 |
Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH |
SERF2 for the treatment of atrophy and for increasing cell growth
|
|
BR112015021708A2
(pt)
|
2013-03-06 |
2017-08-29 |
Protalix Ltd |
Inibidor de polipetídeo do tnfa, polinucleotídeo isolado, estrutura de expressão de ácido nucleico, célula de planta, composição farmacêutica e método de produção de um inibidor de polipeptídeo do tnfa
|
|
US20140257262A1
(en)
|
2013-03-11 |
2014-09-11 |
Alexandre Carpentier |
Interstitial ultrasonic disposable applicator and method for tissue thermal conformal volume ablation and monitoring the same
|
|
EP3666795A1
(en)
|
2013-03-12 |
2020-06-17 |
Molecular Templates, Inc. |
Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
|
|
EP2998322A4
(en)
|
2013-05-14 |
2016-12-14 |
Shanghai Hycharm Inc |
EPITOPOXULENT FOR LOW IMMUNOGENOUS PROTEIN AND METHOD OF PREPARATION AND USE THEREOF
|
|
AU2014364927A1
(en)
|
2013-12-16 |
2016-07-07 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
EP3087101B1
(en)
|
2013-12-20 |
2024-06-05 |
Novartis AG |
Regulatable chimeric antigen receptor
|
|
CA2931005A1
(en)
|
2014-01-15 |
2015-07-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cartilage targeting agents and their use
|
|
WO2015112835A1
(en)
|
2014-01-24 |
2015-07-30 |
COLE Research & Design, Inc. |
Oral suction device
|
|
WO2015116735A1
(en)
|
2014-01-28 |
2015-08-06 |
Mayo Foundation For Medical Education And Research |
Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders
|
|
CA2939121C
(en)
|
2014-01-28 |
2020-11-24 |
Mayo Foundation For Medical Education And Research |
Effective treatment of osteoarthritis, pulmonary disease, ophthalmic disease, and atherosclerosis by removing senescent cells at the site of the disease
|
|
US10238742B2
(en)
|
2014-06-25 |
2019-03-26 |
Yale University |
Cell penetrating nucleolytic antibody based cancer therapy
|
|
IL251210B2
(en)
|
2014-09-19 |
2023-12-01 |
Siwa Corp |
Anti-aging antibodies for the treatment of inflammation and autoimmune disorders
|
|
WO2016061532A1
(en)
*
|
2014-10-16 |
2016-04-21 |
The Broad Institute Inc. |
Compositions and methods for identifying and treating cachexia or pre-cachexia
|
|
US10358502B2
(en)
|
2014-12-18 |
2019-07-23 |
Siwa Corporation |
Product and method for treating sarcopenia
|
|
US9993535B2
(en)
|
2014-12-18 |
2018-06-12 |
Siwa Corporation |
Method and composition for treating sarcopenia
|
|
US10889634B2
(en)
|
2015-10-13 |
2021-01-12 |
Siwa Corporation |
Anti-age antibodies and methods of use thereof
|
|
EP3362483A1
(en)
*
|
2015-10-13 |
2018-08-22 |
Siwa Corporation |
Anti-age antibodies and methods of use thereof
|
|
CN109071675A
(zh)
|
2016-02-19 |
2018-12-21 |
Siwa有限公司 |
使用高级糖化终产物(age)的抗体治疗癌症、杀死转移性癌细胞和预防癌症转移的方法和组合物
|
|
US10981021B2
(en)
|
2016-03-11 |
2021-04-20 |
Carthera |
Method for transiently disrupting a region of the blood-brain barrier of a human
|
|
CA3057829A1
(en)
|
2016-04-15 |
2017-10-19 |
Siwa Corporation |
Anti-age antibodies for treating neurodegenerative disorders
|
|
US10172684B2
(en)
|
2016-04-29 |
2019-01-08 |
Ethicon Llc |
Lifecycle monitoring features for surgical instrument
|
|
EP3475306A1
(en)
|
2016-06-23 |
2019-05-01 |
Siwa Corporation |
Vaccines for use in treating various diseases and disorders
|
|
RU2617313C1
(ru)
|
2016-07-18 |
2017-04-24 |
Государственное автономное учреждение здравоохранения Свердловской области "Центр специализированных видов медицинской помощи "Институт медицинских клеточных технологий" |
Способ определения биологического возраста у мужчин
|
|
US10995151B1
(en)
|
2017-01-06 |
2021-05-04 |
Siwa Corporation |
Methods and compositions for treating disease-related cachexia
|
|
US10961321B1
(en)
|
2017-01-06 |
2021-03-30 |
Siwa Corporation |
Methods and compositions for treating pain associated with inflammation
|
|
US10925937B1
(en)
|
2017-01-06 |
2021-02-23 |
Siwa Corporation |
Vaccines for use in treating juvenile disorders associated with inflammation
|
|
US10858449B1
(en)
|
2017-01-06 |
2020-12-08 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis
|
|
US10919957B2
(en)
|
2017-04-13 |
2021-02-16 |
Siwa Corporation |
Humanized monoclonal advanced glycation end-product antibody
|
|
KR20240006702A
(ko)
|
2017-05-04 |
2024-01-15 |
시와 코퍼레이션 |
진단용 최종 당화 산물 항체
|
|
US11518801B1
(en)
|
2017-12-22 |
2022-12-06 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
|
WO2020023532A1
(en)
|
2018-07-23 |
2020-01-30 |
Siwa Corporation |
Methods and compositions for treating chronic effects of radiation and chemical exposure
|
|
EP3837359A4
(en)
|
2018-08-14 |
2022-05-11 |
Imel Biotherapeutics, Inc. |
Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy
|
|
US20210253739A1
(en)
|
2018-08-23 |
2021-08-19 |
Siwa Corporation |
Anticarboxymethyl lysine antibodies and ultrasound for removing age-modified cells
|
|
AU2021264007A1
(en)
|
2020-05-01 |
2022-12-08 |
Siwa Corporation |
Methods of treating infections
|
|
WO2021247397A2
(en)
|
2020-06-04 |
2021-12-09 |
Siwa Corporation |
Methods and compositions for enhancing the immune system
|
|
WO2022093195A1
(en)
|
2020-10-27 |
2022-05-05 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens
|
|
WO2023023654A1
(en)
|
2021-08-20 |
2023-02-23 |
Siwa Corporation |
Methods and compositions for treating fibrotic diseases
|
|
WO2023177390A1
(en)
|
2022-03-14 |
2023-09-21 |
Siwa Corporation |
Humanized monoclonal advanced glycation end-product antibody for treating pancreatic cancer
|